Abstract:Chemodynamic therapy as a novel type of chemotherapies can damage the DNA structures and induce cell apoptosis and immunogenic cell death (ICD) through generating reactive oxygen species (ROS) to aggravate oxidative stress. Nonetheless, as an intrinsic antioxidative response of tumor cells, the expression of glutathione (GSH) can be upregulated to maintain the cellular redox balance and protect the tumor cells from ROS-mediated damage. In this context, it is feasibly to simultaneous boost ROS generation and GSH depletion in tumor cells, however, the precise delivery and release of GSH scavengers at specitic subcellular sites is of great importance. Herein, we propose a GSH-responsive mesoporous organosilica nanoparticles (MONs)-based nanomedicine MON-CA-TPP@HA through sequentially covalently attaching Triphenylphosphine (TPP) and electrostatic coating hyaluronic acid (HA) onto the surface of cinnamaldehyde (CA) loaded MONs, known as MON-CA-TPP@HA, which has been demonstrated to be an extremely effective therapeutic strategy for cancer treatment through inducing ICD and apoptosis of breast cancer cells. Systematic in vitro experimental results clearly revealed that the nanomedicines can actively target the tumor cells with the help of HA, subsequently entering the tumor cells, and precisely binding with the mitochondria through TPP residues. Upon the cleavage of the disulfide bond in the MONs triggered by over-expressed GSH within tumor, the CA molecules can be released and induce the excessive ROS in situ surrounding the mitochondria to activate oxidative stress to induce apoptosis and ICD of breast cancer cells. The results in vivo experiments confirm that the MON-CA-TPP@HA nanomedicine can effectively promote DCs maturation, CD 8+ T cells activation, and improve the ratio of M1/M2 macrophages which improve tumor immunosuppressive microenvironment. It is thus believed that the current nanomedicines have paved a new way for the future cancer therapy.

Naked mesoporous rhodium nanospheres with glutathione depletion and photothermal capabilities for tumor therapy

Glutathione-sensitive Mesoporous Nanoparticles Loaded with Cinnamaldehyde for Chemodynamic and Immunological Therapy of Cancer

Glutathione-responsive mesoporous silica nanocarriers for chemo–photothermal–photodynamic therapy of cancer

GSH-responsive Prodrug-Based Nanodrugs for Augmenting Chemo-Photodynamic Synergistic Therapy Against Tumors

Au@MnSe2 Core-Shell Nanoagent Enabling Immediate Generation of Hydroxyl Radicals and Simultaneous Glutathione Deletion Free of Pre-Reaction for Chemodynamic-Photothermo-Photocatalytic Therapy with Significant Immune Response.

MnOOH-Catalyzed Autoxidation of Glutathione for Reactive Oxygen Species Production and Nanocatalytic Tumor Innate Immunotherapy

A glutathione responsive pyrrolopyrrolidone nanotheranostic agent for turn-on fluorescence imaging guided photothermal/photodynamic cancer therapy

A hollow Co3-xCuxS4 with glutathione depleting and photothermal properties for synergistic dual-enhanced chemodynamic/photothermal cancer therapy

Photothermal-reinforced and glutathione-triggered <i>in Situ</i> cascaded nanocatalytic therapy

Tumor microenvironment activated glutathione self-depletion theranostic nanocapsules for imaging-directed synergistic cancer therapy

Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation

Copperphosphotungstate Doped Polyanilines Nanorods for GSH-Depletion Enhanced Chemodynamic/NIR-II Photothermal Synergistic Therapy

Targeting Mesoporous Silica-Encapsulated Gold Nanorods for Chemo-Photothermal Therapy with Near-Infrared Radiation

Redox-activatable photothermal therapy and enzyme-mediated tumor starvation for synergistic cancer therapy

GSH‐Depleted Nanozymes with Hyperthermia‐Enhanced Dual Enzyme‐Mimic Activities for Tumor Nanocatalytic Therapy

Bioinspired nanocatalytic tumor therapy by simultaneous reactive oxygen species generation enhancement and glutamine pathway-mediated glutathione depletion

Modulation of Glutathione Levels by Redox‐Active Nanogel Carriers for the Synergistic Enhancement of Photodynamic Therapy

Glutathione-responsive biodegradable nanohybrid for cancer photoacoustic imaging and gas-assisted photothermal therapy

Tumor Microenvironment-Responsive Polymer with Chlorin E6 to Interface Hollow Mesoporous Silica Nanoparticles-Loaded Oxygen Supply Factor for Boosted Photodynamic Therapy.

Dual-responsive and NIR-driven Free Radical Nanoamplifier with Glutathione Depletion for Enhanced Tumor-Specific Photothermal/thermodynamic/chemodynamic Synergistic Therapy.

Amorphous Ultra‐small Fe‐based Nanocluster Engineered and ICG Loaded Organo‐mesoporous Silica for GSH Depletion and Photothermal‐Chemodynamic Synergistic Therapy